Literature DB >> 1846959

Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells.

M R Ehlers1, Y N Chen, J F Riordan.   

Abstract

The testis isozyme of angiotensin-converting enzyme (ACE; EC 3.4.15.1) is a membrane-bound protein that, apart from the first 35 N-terminal residues, is identical to the C-terminal half of somatic ACE and contains the same putative C-terminal membrane anchor. Stable transfection of Chinese hamster ovary (CHO) cells with an expression vector containing the full-length human testis ACE cDNA results in the expression of two forms of recombinant human testis ACE (hTACE): membrane-bound ACE and, surprisingly, large quantities (up to 3 mg/liter) of soluble hTACE in the conditioned medium. Both forms are fully active and are physicochemically similar. However, by phase separation in Triton X-114, the soluble enzyme is hydrophilic, as is an anchor-minus mutant hTACE recovered from the medium of CHO cells transfected with a vector that contains a 3'-truncated testis ACE cDNA lacking the sequence encoding the membrane anchor. In contrast, the membrane-bound hTACE is amphipathic but is converted to a hydrophilic form on treatment with trypsin. The data establish that in ACE the hydrophobic sequence near the C terminus is necessary for membrane anchoring. Moreover, in CHO cells, membrane-bound hTACE is apparently solubilized by proteolytic cleavage of this anchor. A similar mechanism may account for the release of endothelial ACE in vivo to generate serum ACE and more generally for the constitutive processing and solubilization of analogously anchored proteins such as the amyloid precursor protein, among others. The release of membrane-bound ACE in CHO cells may, therefore, provide a useful system for the study of membrane-protein-solubilizing proteases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846959      PMCID: PMC50944          DOI: 10.1073/pnas.88.3.1009

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

2.  Phosphatidylinositol-glycan-tailed membrane proteins: the biochemistry of glycolipid anchors.

Authors:  A J Turner; N M Hooper
Journal:  Biochem Soc Trans       Date:  1989-10       Impact factor: 5.407

3.  Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane.

Authors:  N M Hooper; J Keen; D J Pappin; A J Turner
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

4.  Electronic spectroscopy of cobalt angiotensin converting enzyme and its inhibitor complexes.

Authors:  R Bicknell; B Holmquist; F S Lee; M T Martin; J F Riordan
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

5.  The angiotensin I-converting enzyme.

Authors:  E G Erdös; R A Skidgel
Journal:  Lab Invest       Date:  1987-04       Impact factor: 5.662

6.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

7.  Structure-function relationships for the IL 2-receptor system. IV. Analysis of the sequence and ligand-binding properties of soluble Tac protein.

Authors:  R J Robb; R M Kutny
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

8.  Rapid affinity chromatographic purification of human lung and kidney angiotensin-converting enzyme with the novel N-carboxyalkyl dipeptide inhibitor N-[1(S)-carboxy-5-aminopentyl]glycylglycine.

Authors:  M R Ehlers; D L Maeder; R E Kirsch
Journal:  Biochim Biophys Acta       Date:  1986-09-04

9.  Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

Authors:  F Soubrier; F Alhenc-Gelas; C Hubert; J Allegrini; M John; G Tregear; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Molecular cloning and amino acid sequence of rat enkephalinase.

Authors:  B Malfroy; P R Schofield; W J Kuang; P H Seeburg; A J Mason; W J Henzel
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

View more
  21 in total

1.  Shedding of somatic angiotensin-converting enzyme (ACE) is inefficient compared with testis ACE despite cleavage at identical stalk sites.

Authors:  Z L Woodman; S Y Oppong; S Cook; N M Hooper; S L Schwager; W F Brandt; M R Ehlers; E D Sturrock
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

2.  Use of alternative polyadenylation sites for tissue-specific transcription of two angiotensin-converting enzyme mRNAs.

Authors:  T J Thekkumkara; W Livingston; R S Kumar; G C Sen
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity.

Authors:  Zenda L Woodman; Sylva L U Schwager; Pierre Redelinghuys; Adriana K Carmona; Mario R W Ehlers; Edward D Sturrock
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

Review 4.  Membrane protein secretases.

Authors:  N M Hooper; E H Karran; A J Turner
Journal:  Biochem J       Date:  1997-01-15       Impact factor: 3.857

5.  Cleavage of arginyl-arginine and lysyl-arginine from the C-terminus of pro-hormone peptides by human germinal angiotensin I-converting enzyme (ACE) and the C-domain of human somatic ACE.

Authors:  R E Isaac; T A Williams; M Sajid; P Corvol; D Coates
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

Review 6.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

7.  Expression of rat endopeptidase-24.18 in COS-1 cells: membrane topology and activity.

Authors:  P E Milhiet; D Corbeil; V Simon; A J Kenny; P Crine; G Boileau
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

8.  Characterization of a secretase activity which releases angiotensin-converting enzyme from the membrane.

Authors:  S Y Oppong; N M Hooper
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

9.  Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes.

Authors:  O Costerousse; J Allegrini; M Lopez; F Alhenc-Gelas
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

10.  Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE.

Authors:  Andrew B Nesterovitch; Kyle D Hogarth; Vyacheslav A Adarichev; Elena I Vinokour; David E Schwartz; Julian Solway; Sergei M Danilov
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.